CG
ATRA icon

Cutler Group’s Atara Biotherapeutics ATRA Stock Holding History

Cutler Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60
Closed -$2.67K – 3763
2023
Q2 		$2K Buy
60
+12
+25% +$679 ﹤0.01% 2956
2023
Q1 		$3K Buy
+48
New +$4.66K ﹤0.01% 2906
2022
Q3 		– Sell
-36
Closed -$7K – 4888
2022
Q2 		$7K Buy
+36
New +$5.88K ﹤0.01% 3428
2021
Q4 		– Sell
-12
Closed -$5K – 5351
2021
Q3 		$5K Hold
12
– – ﹤0.01% 4412
2021
Q2 		$4K Hold
12
– – ﹤0.01% 4544
2021
Q1 		$4K Hold
12
– – ﹤0.01% 4466
2020
Q4 		$5K Sell
12
-8
-40% -$3.69K ﹤0.01% 3614
2020
Q3 		$6K Buy
+20
New +$6.81K ﹤0.01% 3320
2020
Q2 		– Sell
-28
Closed -$7.07K – 4357
2020
Q1 		$5K Buy
+28
New +$8.89K ﹤0.01% 3048
2018
Q1 		– Sell
-20
Closed -$18.2K – 4421
2017
Q4 		$9K Sell
20
-84
-81% -$31K ﹤0.01% 3187
2017
Q3 		$43K Sell
104
-8
-7% -$3.02K ﹤0.01% 2370
2017
Q2 		$39K Buy
112
+32
+40% +$12.3K ﹤0.01% 2737
2017
Q1 		$41K Buy
80
+76
+1,900% +$31.5K ﹤0.01% 2605
2016
Q4 		$1K Sell
4
-28
-88% -$11.9K ﹤0.01% 5881
2016
Q3 		$17K Hold
32
– – ﹤0.01% 3575
2016
Q2 		$18K Buy
+32
New +$15.4K ﹤0.01% 3462
2016
Q1 		– Sell
-12
Closed -$5.4K – 6446
2015
Q4 		$7K Buy
+12
New +$9.08K ﹤0.01% 4503

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cutler Group's ATRA Position: Q3 2023 in Review

Cutler Group sold out of Atara Biotherapeutics (ATRA) in Q3 2023, closing a stake of 60 shares — an estimated $2.67K sold.

Cutler Group first reported a position in ATRA in Q4 2015 and held it in 17 quarters. The position peaked at $43K in Q3 2017. 109 funds tracked by Wall St. Rank hold ATRA as of Q3 2023.

  • Cutler Group reported no remaining Atara Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 60 Atara Biotherapeutics shares in Q3 2023, an estimated $2.67K.
  • Cutler Group first reported a position in Atara Biotherapeutics in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Atara Biotherapeutics position peaked at $43K in Q3 2017.
  • 109 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.